Accenture plc - Annual Report: 2024 (Form 10-K)


Health & Public Service
FY24 Revenues of $13.8B
Percent of Group’s FY24 Revenue

31%			69%
Health			Public Service
Healthcare providers, such as hospitals, public health systems, policy-making authorities, health insurers (payers), and industry organizations and associations			Defense departments and military forces; public safety authorities; justice departments; human and social services agencies; educational institutions; non-profit organizations; cities; transportation agencies; and postal, customs, revenue and tax agencies


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 1. Business	8

Our work with clients in the U.S. federal government is delivered through Accenture Federal Services, a U.S. company and a wholly owned subsidiary of Accenture LLP, and represented approximately 37% of our Health & Public Service industry group’s revenues and 17% of our North America revenues in fiscal 2024.


Products
FY24 Revenues of $19.6B
Percent of Group’s FY24 Revenue

46%	34%	20%
Consumer Goods, Retail & Travel Services	Industrial	Life Sciences
Food and beverage, household goods, personal care, tobacco, fashion/apparel, agribusiness and consumer health companies; supermarkets, hardline retailers, mass-merchandise discounters, department, quickserve and convenience stores and specialty retailers; aviation; and hospitality and travel services companies	Industrial & electrical equipment manufacturers and industrial suppliers; and construction, heavy equipment, consumer durables, engineering services, real estate, freight & logistics, aerospace & defense, automotive & mobility and public transportation companies	Biopharmaceutical, medical technology and distributors


Resources
FY24 Revenues of $9.1B
Percent of Group’s FY24 Revenue

29%	25%	46%
Chemicals & Natural Resources	Energy	Utilities
Petrochemicals, specialty chemicals, polymers and plastics, gases and agricultural chemicals companies, as well as the metals, mining, forest products and building materials industries	Oil and gas industries, including upstream, midstream, downstream, oilfield services, clean energy and energy trading companies	Power generators and developers, including nuclear, renewables and other conventional generators; electric and gas transmission and distribution operators, energy and energy service retailers; water, waste and recycling service providers

Resources9.1 8.9 %Managed Services31.7 30.5 (in billions of U.S. dollars)20242023 %$161

Amounts in table may not total due to rounding.

(1)Costs recorded in connection with our business optimization initiatives, primarily for employee severance.

(2)During the first quarter of fiscal 2024, we revised the reporting of our geographic markets for the movement of our Middle East and Africa market units from Growth Markets to Europe, and the Europe market became our EMEA (Europe, Middle East and Africa) geographic market. Prior period amounts have been reclassified to conform with the current period presentation.

Other Income (Expense), net

Other income (expense), net primarily consists of foreign currency gains and losses, non-operating components of pension expense, as well as gains and losses associated with our investments. During fiscal 2024, Other income (expense), net decreased $206 million from fiscal 2023, primarily due to lower gains on investments.


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations	45

Income Tax Expense

The effective tax rate for fiscal 2024 was 23.5%, compared with 23.4% for fiscal 2023.

Income Tax Expense Excluding Business Optimization Costs and Investment Gain (Non-GAAP)

Excluding the business optimization costs of $438 million and related reduction in tax expense of $111 million, our adjusted effective tax rate was 23.6% for fiscal 2024. Excluding the business optimization costs of $1,063 million and related reduction in tax expense of $247 million, and the investment gain of $253 million and related tax expense of $9 million, our adjusted effective tax rate was 23.9% for fiscal 2023.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests reflects the income earned or expense incurred attributable to the equity interest that some current and former members of Accenture Leadership and their permitted transferees have in our Accenture Canada Holdings Inc. subsidiary. See “Business—Organizational Structure.” Noncontrolling interests also includes amounts primarily attributable to noncontrolling shareholders in our Avanade Inc. subsidiary. Net income attributable to Accenture plc represents the income attributable to the shareholders of Accenture plc.

Earnings Per Share

Diluted earnings per share were $11.44 for fiscal 2024, compared with $10.77 for fiscal 2023. For information regarding our earnings per share calculations, see Note 3 (Earnings Per Share) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

Earnings Per Share Excluding Business Optimization Costs and Investment Gain (Non-GAAP)

The business optimization costs of $327 million, net of related taxes, decreased diluted earnings per share by $0.51 for fiscal 2024. Adjusted diluted earnings per share were $11.95 for fiscal 2024. The business optimization costs of $816 million, net of related taxes, decreased diluted earnings per share by $1.28 and the investment gain of $244 million, net of related taxes, increased diluted earnings per share by $0.38 for fiscal 2023. Adjusted diluted earnings per share were $11.67 for fiscal 2023.


	Fiscal
FY24 As Reported	$	11.44
Business optimization costs	0.69
Tax effect of business optimization costs (1)	(0.18)
FY24 As Adjusted	$	11.95

FY23 As Reported	$	10.77
Business optimization costs	1.66
Gain on an investment	(0.40)
Tax effect of business optimization costs and gain on an investment (1)	(0.37)
FY23 As Adjusted	$	11.67

Amounts in table may not total due to rounding.

(1)The income tax effect of business optimization costs and gain on an investment include both the current and deferred income tax impact and was calculated by using the relevant tax rate of the country where the adjustments were recorded.

The increase in adjusted diluted earnings per share is due to the following factors:


	Fiscal
FY23 As Adjusted	$	11.67
Higher revenue and operating results	0.19
Lower share count	0.05
Lower effective tax rate	0.05
Higher non-operating income	0.02
Higher net income attributable to noncontrolling interests	(0.03)
FY24 As Adjusted	$	11.95


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations	46

Our operating income and diluted earnings per share are affected by currency exchange rate fluctuations on revenues and costs. Most of our costs are incurred in the same currency as the related revenues. Where practical, we seek to manage foreign currency exposure for costs not incurred in the same currency as the related revenues, such as the costs associated with our global delivery model, by using currency protection provisions in our customer contracts and through our hedging programs. We seek to manage our costs, taking into consideration the residual positive and negative effects of changes in foreign exchange rates on those costs. For more information on our hedging programs, see Foreign Currency Risk under Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” and Note 9 (Financial Instruments) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

Results of Operations for Fiscal 2023 Compared to Fiscal 2022

Our Annual Report on Form 10-K for the fiscal year ended August 31, 2023 includes a discussion and analysis of our financial condition and results of operations for the year ended August 31, 2022 in Item 7 of Part II, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations	47

Liquidity and Capital Resources

Our primary sources of liquidity are cash flows from operations, available cash reserves, debt capacity available under various credit facilities and other borrowings. We could raise additional funds through other public or private debt or equity financings. We may use our available or additional funds to, among other things:

•facilitate purchases, redemptions and exchanges of shares and pay dividends;

•acquire complementary businesses or technologies;

•take advantage of opportunities, including more rapid expansion;

•develop new services and solutions; or

•repay outstanding borrowings and other debt.

See Note 10 (Borrowings and Indebtedness) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data” for further information regarding our outstanding borrowings and other debt.

As of August 31, 2024, Cash and cash equivalents were $5.0 billion, compared with $9.0 billion as of August 31, 2023.

Cash flows from operating, investing and financing activities, as reflected in our Consolidated Cash Flows Statements, are summarized in the following table:


	Fiscal				Change
(in millions of U.S. dollars)	2024		2023
Net cash provided by (used in):
Operating activities	$	9,131	$	9,524	$	(393)
Investing activities	(7,062)		(2,622)		(4,439)
Financing activities	(6,064)		(5,645)		(418)
Effect of exchange rate changes on cash and cash equivalents	(46)		(101)		55
Net increase (decrease) in cash and cash equivalents	$	(4,041)	$	1,155	$	(5,196)

Amounts in table may not total due to rounding.

Operating activities: The $393 million decrease in operating cash flows was primarily due to changes in operating assets and liabilities, including receivables from clients and contract assets, partially offset by higher net income.

Investing activities: The $4,439 million increase in cash used was primarily due to higher spending on business acquisitions. For additional information, see Note 6 (Business Combinations and Dispositions) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

Financing activities: The $418 million increase in cash used was due to higher cash dividends paid and net purchases of shares, as well as higher purchases of noncontrolling interests, partially offset by higher net proceeds from borrowings. For additional information, see Note 14 (Shareholders’ Equity) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

We believe that our current and longer-term working capital, investments and other general corporate funding requirements will be satisfied for the next twelve months and thereafter through cash flows from operations and, to the extent necessary, from our borrowing facilities and future financial market activities.

Substantially all of our cash is held in jurisdictions where there are no regulatory restrictions or material tax effects on the free flow of funds. Domestic cash inflows for our Irish parent, principally dividend distributions from lower-tier subsidiaries, have been sufficient to meet our historic cash requirements, and we expect this to continue into the future.

Share Purchases and Redemptions

We intend to continue to use a significant portion of cash generated from operations for share repurchases during fiscal 2025. The number of shares ultimately repurchased under our open-market share purchase program may vary depending on numerous factors, including, without limitation, share price and other market conditions, our ongoing capital allocation planning, the levels of cash and debt balances, other demands for cash, such as acquisition activity, general economic and/or business conditions, and board and management discretion. Additionally, as these factors may change over the course of the year, the amount of share repurchase activity during any particular period cannot be predicted and may fluctuate from time to time. Share repurchases may be made from time to time through open-market purchases, in respect of purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares, through the use of Rule 10b5-1 plans and/or by


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations	48

other means. The repurchase program may be accelerated, suspended, delayed or discontinued at any time, without notice. For additional information, see Note 14 (Shareholders’ Equity) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

Subsequent Events

See Note 10 (Borrowings and Indebtedness) and Note 14 (Shareholders’ Equity) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

Obligations and Commitments

As of August 31, 2024, we had commitments of $3.4 billion related to cloud hosting arrangements, software subscriptions, information technology services and other obligations in the ordinary course of business that we cannot cancel or where we would be required to pay a termination fee in the event of cancellation. Payments under these commitments are estimated to be made as follows:


(in millions of U.S. dollars)	Payments (1)
Less than 1 year	$	1,068
1-3 years	1,352
3-5 years	870
More than 5 years	80
Total	$	3,370

(1)Amounts do not include recourse that we may have to recover termination fees or penalties from clients.

For information about borrowing facilities and leases, see Note 10 (Borrowings and Indebtedness) and Note 8 (Leases) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

Off-Balance Sheet Arrangements

In the normal course of business and in conjunction with some client engagements, we have entered into contractual arrangements through which we may be obligated to indemnify clients with respect to certain matters. To date, we have not been required to make any significant payment under any of these arrangements. For further discussion of these transactions, see Note 15 (Commitments and Contingencies) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

New Accounting Pronouncements

See Note 1 (Summary of Significant Accounting Policies) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 7A. Quantitative and Qualitative Disclosures About Market Risk	49

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

All of our market risk sensitive instruments were entered into for purposes other than trading.

Foreign Currency Risk

We are exposed to foreign currency risk in the ordinary course of business. We hedge material cash flow exposures when feasible using forward contracts. These instruments are subject to fluctuations in foreign currency exchange rates and credit risk. Credit risk is managed through careful selection and ongoing evaluation of the financial institutions utilized as counterparties.

Certain of these hedge positions are undesignated hedges of balance sheet exposures such as intercompany loans and typically have maturities of less than one year. These hedges, the most significant of which are U.S. dollar/Euro, U.S. dollar/Indian rupee, U.S. dollar/Japanese yen, U.S. dollar/U.K. pound, U.S. dollar/Swiss franc, U.S. dollar/Chinese yuan, U.S. dollar/Australian dollar and U.S. dollar/Philippine peso, are intended to offset remeasurement of the underlying assets and liabilities. Changes in the fair value of these derivatives are recorded in Other income (expense), net in the Consolidated Income Statements. Additionally, we have hedge positions that are designated cash flow hedges of certain intercompany charges relating to our global delivery model. These hedges, the most significant of which are U.S. dollar/Indian rupee, U.S. dollar/Philippine peso, Euro/Indian rupee and U.K. pound/Indian rupee, typically have maturities not exceeding three years and are intended to partially offset the impact of foreign currency movements on future costs relating to our global delivery resources. For additional information, see Note 9 (Financial Instruments) to our Consolidated Financial Statements under Item 8, “Financial Statements and Supplementary Data.”

For designated cash flow hedges, gains and losses currently recorded in Accumulated other comprehensive loss are expected to be reclassified into earnings at the time when certain anticipated intercompany charges are accrued as Cost of services. As of August 31, 2024, it was anticipated that approximately $22 million of net gains, net of tax, currently recorded in Accumulated other comprehensive loss will be reclassified into Cost of services within the next 12 months.

We use sensitivity analysis to determine the effects that market foreign currency exchange rate fluctuations may have on the fair value of our hedge portfolio. The sensitivity of the hedge portfolio is computed based on the market value of future cash flows as affected by changes in exchange rates. This sensitivity analysis represents the hypothetical changes in value of the hedge position and does not reflect the offsetting gain or loss on the underlying exposure. A 10% change in the levels of foreign currency exchange rates against the U.S. dollar (or other base currency of the hedge if not a U.S. dollar hedge) with all other variables held constant would have resulted in a change in the fair value of our hedge instruments of approximately $655 million and $856 million as of August 31, 2024 and 2023, respectively.

Interest Rate Risk

The interest rate risk associated with our borrowing and investing activities as of August 31, 2024 is not material in relation to our consolidated financial position, results of operations or cash flows. While we may do so in the future, we have not used derivative financial instruments to alter the interest rate characteristics of our investment holdings or debt instruments.

Equity Investment Risk

Our non-marketable and marketable equity securities are subject to a wide variety of market-related risks that could substantially reduce or increase the fair value of our investments.

Our non-marketable equity securities are investments in privately held companies which are often in a start-up or development stage, which is inherently risky. The technologies or products these companies have under development are typically in the early stages and may never materialize, which could result in a loss of a substantial part of our investment in these companies. The evaluations of privately held companies are based on information that we request from these companies, which is not subject to the same disclosure regulations as U.S. publicly traded companies, and as such, the basis for these evaluations is subject to the timing and accuracy of the data received from these companies. We have minimal exposure on our long-term investments in privately held companies as these investments were not material in relation to our consolidated financial position, results of operations or cash flows as of August 31, 2024.


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 7A. Quantitative and Qualitative Disclosures About Market Risk	50

We record our marketable equity securities not accounted for under the equity method at fair value based on readily determinable market values.

The carrying values of our investments accounted for under the equity method generally do not fluctuate based on market price changes; however, these investments could be impaired if the carrying value exceeds the fair value.

Item 8. Financial Statements and Supplementary Data

See the Index to Consolidated Financial Statements and financial statements commencing on page F-1, which are incorporated herein by reference.

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on that evaluation, the principal executive officer and the principal financial officer of Accenture plc have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective at the reasonable assurance level.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that:

i.pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 9A. Controls and Procedures	51

ii.provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of management and our Board of Directors; and

iii.provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework (2013). Based on its evaluation, our management concluded that our internal control over financial reporting was effective as of the end of the fiscal year covered by this Annual Report on Form 10-K.

KPMG LLP, an independent registered public accounting firm, has audited the Consolidated Financial Statements included in this Annual Report on Form 10-K and, as part of their audit, has issued its attestation report, included herein, on the effectiveness of our internal control over financial reporting. See “Report of Independent Registered Public Accounting Firm” on page F-2.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the fourth quarter of fiscal 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information

Trading Arrangements

or by our executive officers or directors during the fourth quarter of fiscal 2024. All of the trading arrangements listed below are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Name

Title

Date of Adoption or Termination

Duration of Plan (1)

Aggregate number of Class A ordinary shares to be sold pursuant to the trading agreement (2)

Adopted on

October 21, 2024 - July 24, 2025

Adopted on

October 22, 2024 - July 24, 2025

(1) Each plan will expire on the earlier of the expiration date or the completion of all transactions under the trading arrangement.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

None.


Table of Contents
ACCENTURE 2024 FORM 10-K	Part III	52

Part III

Item 10. Directors, Executive Officers and Corporate Governance

There have been no material changes to the procedures by which security holders may recommend nominees to our Board of Directors from those described in the proxy statement for our 2024 Annual General Meeting of Shareholders filed with the SEC on December 13, 2023.

Information about our executive officers is contained in the discussion entitled “Information about our Executive Officers” in Part I of this Form 10-K. The remaining information called for by Item 10 will be included in the sections captioned “Appointment of Directors,” “Corporate Governance” and “Beneficial Ownership” included in the definitive proxy statement relating to the 2025 Annual General Meeting of Shareholders of Accenture plc to be held on February 6, 2025 and is incorporated herein by reference. Accenture plc will file such definitive proxy statement with the SEC pursuant to Regulation 14A not later than 120 days after the end of our 2024 fiscal year covered by this Form 10-K.

Item 11. Executive Compensation

The information called for by Item 11 will be included in the sections captioned “Executive Compensation” and “Director Compensation” included in the definitive proxy statement relating to the 2025 Annual General Meeting of Shareholders of Accenture plc to be held on February 6, 2025 and is incorporated herein by reference. Accenture plc will file such definitive proxy statement with the SEC pursuant to Regulation 14A not later than 120 days after the end of our 2024 fiscal year covered by this Form 10-K.


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters	53

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

Securities Authorized for Issuance under Equity Compensation Plans

The following table sets forth, as of August 31, 2024, certain information related to our compensation plans under which Accenture plc Class A ordinary shares may be issued.


Plan Category	Number of Shares to be Issued Upon Exercise of Outstanding Options, Warrants and Rights		Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights (3)		Number of Shares Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in 1st Column)
Equity compensation plans approved by shareholders:
2001 Share Incentive Plan	9,265	(1)	$	—	—
Amended and Restated 2010 Share Incentive Plan	16,220,558	(2)	—		27,270,917
Amended and Restated 2010 Employee Share Purchase Plan	—		N/A		50,575,968
Equity compensation plans not approved by shareholders	—		N/A		—
Total	16,229,823				77,846,885

(1)Consists of 9,265 restricted share units.

(2)Consists of 16,220,558 restricted share units, with performance-based awards assuming maximum performance.

(3)Restricted share units have no exercise price.

The remaining information called for by Item 12 will be included in the section captioned “Beneficial Ownership” included in the definitive proxy statement relating to the 2025 Annual General Meeting of Shareholders of Accenture plc to be held on February 6, 2025 and is incorporated herein by reference. Accenture plc will file such definitive proxy statement with the SEC pursuant to Regulation 14A not later than 120 days after the end of our 2024 fiscal year covered by this Form 10-K.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information called for by Item 13 will be included in the section captioned “Corporate Governance” included in the definitive proxy statement relating to the 2025 Annual General Meeting of Shareholders of Accenture plc to be held on February 6, 2025 and is incorporated herein by reference. Accenture plc will file such definitive proxy statement with the SEC pursuant to Regulation 14A not later than 120 days after the end of our 2024 fiscal year covered by this Form 10-K.


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 14. Principal Accountant Fees and Services	54

Item 14. Principal Accountant Fees and Services

The information called for by Item 14 will be included in the section captioned “Audit” included in the definitive proxy statement relating to the 2025 Annual General Meeting of Shareholders of Accenture plc to be held on February 6, 2025 and is incorporated herein by reference. Accenture plc will file such definitive proxy statement with the SEC pursuant to Regulation 14A not later than 120 days after the end of our 2024 fiscal year covered by this Form 10-K.


Table of Contents
ACCENTURE 2024 FORM 10-K	Part IV	55

Part IV

Item 15. Exhibits, Financial Statement Schedules

(a) List of documents filed as part of this report:

1. Financial Statements as of August 31, 2024 and 2023 and for the three years ended August 31, 2024—Included in Part II of this Form 10-K:

Consolidated Balance Sheets

Consolidated Income Statements

Consolidated Statements of Comprehensive Income

Consolidated Shareholders’ Equity Statements

Consolidated Cash Flows Statements

Notes to Consolidated Financial Statements

2. Financial Statement Schedules:

None

3. Exhibit Index:

Exhibit
Number

Exhibit

3.1

Amended and Restated Memorandum and Articles of Association of Accenture plc (incorporated by reference to Exhibit 3.1 to Accenture plc’s 8-K filed on February 7, 2018)

3.2

Certificate of Incorporation of Accenture plc (incorporated by reference to Exhibit 3.2 to Accenture plc’s 8-K12B filed on September 1, 2009 (the “8-K12B”))

4.1

Description of Accenture plc’s Securities (filed herewith)

4.2

Indenture, among Accenture Capital Inc., Accenture plc and The Bank of New York Mellon Trust Company, N.A., dated as of October 4, 2024 (incorporated by reference to Exhibit 4.1 to Accenture plc’s 8-K filed on October 4, 2024)

4.3

Officer’s Certificate of Accenture Capital Inc., dated as of October 4, 2024, containing Form of 3.900% Note due 2027, Form of 4.050% Note due 2029, Form of 4.250% Note due 2031 and Form of 4.500% Note due 2034 (incorporated by reference to Exhibit 4.2 to Accenture plc’s 8-K filed on October 4, 2024)

10.1

Form of Voting Agreement, dated as of April 18, 2001, among Accenture Ltd and the covered persons party thereto as amended and restated as of February 3, 2005 (incorporated by reference to Exhibit 9.1 to the Accenture Ltd February 28, 2005 10-Q (File No. 001-16565))

10.2

Assumption Agreement of the Amended and Restated Voting Agreement, dated September 1, 2009 (incorporated by reference to Exhibit 10.4 to the 8-K12B)

10.3*

Form of Non-Competition Agreement, dated as of April 18, 2001, among Accenture Ltd and certain employees (incorporated by reference to Exhibit 10.2 to the Accenture Ltd Registration Statement on Form S-1 (File No. 333-59194) filed on April 19, 2001)

10.4

Assumption and General Amendment Agreement between Accenture plc and Accenture Ltd, dated September 1, 2009 (incorporated by reference to Exhibit 10.1 to the 8-K12B)

10.5*

2001 Share Incentive Plan (incorporated by reference to Exhibit 10.3 to the Accenture Ltd Registration Statement on Form S-1/A (File No. 333-59194) filed on July 12, 2001)

10.6*

Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to Exhibit 10.1 to Accenture plc’s 8-K filed on January 31, 2024)


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 15. Exhibits, Financial Statement Schedules	56

10.7*

Amended and Restated 2010 Employee Share Purchase Plan (incorporated by reference to Exhibit 10.2 to Accenture plc’s 8-K filed on January 31, 2024)

10.8

Credit Agreement, dated as of May 14, 2024, among Accenture plc, the borrowers party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 to Accenture plc’s 8-K filed on May 17, 2024)

10.9

Form of Support Agreement, dated as of May 23, 2001, between Accenture Ltd and Accenture Canada Holdings Inc. (incorporated by reference to Exhibit 10.9 to the Accenture Ltd Registration Statement on Form S-1/A (the “July 2, 2001 Form S-1/A”))

10.10

First Supplemental Agreement to Support Agreement among Accenture plc, Accenture Ltd and Accenture Canada Holdings Inc., dated September 1, 2009 (incorporated by reference to Exhibit 10.2 to the 8-K12B)

10.11*

Form of Employment Agreement of executive officers in the United States (incorporated by reference to Exhibit 10.3 to the February 28, 2013 10-Q)

10.12*

2012 Employment Contract between Accenture SAS and Jean-Marc Ollagnier, together with 2017 and 2022 Addenda (incorporated by reference to Exhibit 10.12 to the August 31, 2022 10-K)

10.13

Form of Articles of Association of Accenture Canada Holdings Inc. (incorporated by reference to Exhibit 10.11 to the July 2, 2001 Form S-1/A)

10.14

Articles of Amendment to Articles of Association of Accenture Canada Holdings Inc. (incorporated by reference to Exhibit 10.21 to the August 31, 2013 10-K)

10.15

Form of Exchange Trust Agreement by and between Accenture Ltd and Accenture Canada Holdings Inc. and CIBC Mellon Trust Company, made as of May 23, 2001 (incorporated by reference to Exhibit 10.12 to the July 2, 2001 Form S-1/A)

10.16

First Supplemental Agreement to Exchange Trust Agreement among Accenture plc, Accenture Ltd, Accenture Canada Holdings Inc. and Accenture Inc., dated September 1, 2009 (incorporated by reference to Exhibit 10.3 to the 8-K12B)

10.17*

2015 Sub-plan for Restricted Share Units Granted in France, as amended (incorporated by reference to Exhibit 10.1 to the February 28, 2022 10-Q )

10.18*

Form of Director Restricted Share Unit Agreement pursuant to the Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to Exhibit 10.1 to the February 29, 2024 10-Q)

10.19*

Form of Key Executive Performance-Based Award Restricted Share Unit Agreement pursuant to the Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to Exhibit 10.3 to the February 28, 2022 10-Q)

10.20*

10.21*

10.22*

Form of Fiscal 2022 Key Executive Performance-Based Award Restricted Share Unit Agreement in France (incorporated by reference to Exhibit 10.7 to the February 28, 2022 10-Q)

10.23*

Form of Fiscal 2023 Key Executive Performance-Based Award Restricted Share Unit Agreement in France (incorporated by reference to Exhibit 10.6 to the February 28, 2023 10-Q)

10.24*

Form of Fiscal 2024 Key Executive Performance-Based Award Restricted Share Unit Agreement in France (incorporated by reference to Exhibit 10.6 to the February 29, 2024 10-Q)

10.25*

Form of Accenture Leadership Performance Equity Award Restricted Share Unit Agreement pursuant to the Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to Exhibit 10.4 to the February 28, 2022 10-Q)

10.26*

10.27*

10.28*

Form of Accenture Leadership Performance Equity Award Restricted Share Unit Agreement in France (incorporated by reference to Exhibit 10.7 to the February 29, 2024 10-Q)

10.29*

Form of Voluntary Equity Investment Program Matching Grant Restricted Share Unit Agreement pursuant to the Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to Exhibit 10.4 to the February 28, 2023 10-Q)

10.30*

10.31*

Form of CEO Discretionary Grant Restricted Share Unit Agreement pursuant to the Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to Exhibit 10.5 to the February 29, 2024 10-Q )

10.32*

Description of Global Annual Bonus Plan (incorporated by reference to Exhibit 10.9 to the February 28, 2022 10-Q)

10.33*

Form of Indemnification Agreement, between Accenture Inc. and the indemnitee party thereto (incorporated by reference to Exhibit 10.28 to the August 31, 2018 10-K)

10.34*

Form of Severance Agreement (incorporated by reference to Exhibit 10.1 to the December 19, 2023 10-Q)

10.35*

Relocation Benefits Agreement between Accenture LLP and Manish Sharma (incorporated by reference to Exhibit 10.2 to the December 19, 2023 10-Q)


Table of Contents
ACCENTURE 2024 FORM 10-K	Item 15. Exhibits, Financial Statement Schedules	57


10.36*						Retirement Agreement between Accenture LLP and Jimmy Etheredge (incorporated by reference to Exhibit 10.12 to the August 31, 2023 10-K)
19.1						Insider Trading Policy (filed herewith)
21.1						Subsidiaries of the Registrant (filed herewith)
23.1						Consent of KPMG LLP (filed herewith)
23.2						Consent of KPMG LLP related to the Accenture plc 2010 Employee Share Purchase Plan (filed herewith)
24.1						Power of Attorney (included on the signature page hereto)
31.1						Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
31.2						Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.1						Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
32.2						Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
97.1*						Mandatory Recoupment Policy (incorporated by reference to Exhibit 97.1 to the August 31, 2023 10-K)
99.1						Amended and Restated Accenture plc 2010 Employee Share Purchase Plan Financial Statements (filed herewith)
101						The following financial information from Accenture plc’s Annual Report on Form 10-K for the fiscal year ended August 31, 2024, formatted in Inline XBRL: (i) Consolidated Balance Sheets as of August 31, 2024 and August 31, 2023, (ii) Consolidated Income Statements for the years ended August 31, 2024, 2023 and 2022, (iii) Consolidated Statements of Comprehensive Income for the years ended August 31, 2024, 2023 and 2022, (iv) Consolidated Shareholders’ Equity Statements for the years ended August 31, 2024, 2023 and 2022, (v) Consolidated Cash Flows Statements for the years ended August 31, 2024, 2023 and 2022, and (vi) the Notes to Consolidated Financial Statements
104						The cover page from Accenture plc’s Annual Report on Form 10-K for the year ended August 31, 2024, formatted in Inline XBRL (included as Exhibit 101)


(*)			Indicates management contract or compensatory plan or arrangement.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

Item 16. Form 10-K Summary

Not applicable.


Table of Contents
ACCENTURE 2024 FORM 10-K	Signatures	58

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf on October 10, 2024 by the undersigned, thereunto duly authorized.


ACCENTURE PLC

By:			/s/ JULIE SWEET
			Name: Julie Sweet Title: Chief Executive Officer

Power of Attorney

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Julie Sweet, KC McClure and Joel Unruch, and each of them, as his or her true and lawful attorneys-in-fact and agents, with power to act with or without the others and with full power of substitution and resubstitution, to do any and all acts and things and to execute any and all instruments which said attorneys and agents and each of them may deem necessary or desirable to enable the registrant to comply with the U.S. Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the U.S. Securities and Exchange Commission thereunder in connection with the registrant’s Annual Report on Form 10-K for the fiscal year ended August 31, 2024 (the “Annual Report”), including specifically, but without limiting the generality of the foregoing, power and authority to sign the name of the registrant and the name of the undersigned, individually and in his or her capacity as a director or officer of the registrant, to the Annual Report as filed with the U.S. Securities and Exchange Commission, to any and all amendments thereto, and to any and all instruments or documents filed as part thereof or in connection therewith; and each of the undersigned hereby ratifies and confirms all that said attorneys and agents and each of them shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on October 10, 2024 by the following persons on behalf of the registrant and in the capacities indicated.


Signature						Title


/s/ JULIE SWEET						Chief Executive Officer, Chair of the Board and Director
Julie Sweet						(principal executive officer)

/s/ KC MCCLURE						Chief Financial Officer
KC McClure						(principal financial officer)

/s/ MELISSA A. BURGUM						Chief Accounting Officer
Melissa A. Burgum						(principal accounting officer)

/s/ GILLES C. PÉLISSON						Lead Director
Gilles C. Pélisson

/s/ JAIME ARDILA						Director
Jaime Ardila


Table of Contents
ACCENTURE 2024 FORM 10-K	Signatures	59




/s/ MARTIN BRUDERMÜLLER						Director
Martin Brudermüller

/s/ ALAN JOPE						Director
Alan Jope

/s/ NANCY MCKINSTRY						Director
Nancy McKinstry

/s/ BETH E. MOONEY						Director
Beth E. Mooney

/s/ PAULA A. PRICE						Director
Paula A. Price

/s/ VENKATA S.M. RENDUCHINTALA						Director
Venkata S.M. Renduchintala

/s/ ARUN SARIN						Director
Arun Sarin

/s/ TRACEY T. TRAVIS						Director
Tracey T. Travis


Table of Contents
ACCENTURE 2024 FORM 10-K	Index to Consolidated Financial Statements	F-1

Accenture plc

Index to Consolidated Financial Statements



						Page
Report of Independent Registered Public Accounting Firm (Auditor Firm ID: )						F-2
Consolidated Financial Statements as of August 31, 2024 and 2023 and for the years ended August 31, 2024, 2023 and 2022:
Consolidated Balance Sheets						F-5
Consolidated Income Statements						F-6
Consolidated Statements of Comprehensive Income						F-7
Consolidated Shareholders’ Equity Statements						F-8
Consolidated Cash Flows Statements						F-11
Notes to Consolidated Financial Statements						F-12


Table of Contents
ACCENTURE 2024 FORM 10-K	Report of Independent Registered Public Accounting Firm	F-2

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors

Accenture plc:

Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting

We have audited the accompanying consolidated balance sheets of Accenture plc and subsidiaries (the Company) as of August 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended August 31, 2024, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of August 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of August 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended August 31, 2024, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of August 31, 2024 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.


Table of Contents
ACCENTURE 2024 FORM 10-K	Report of Independent Registered Public Accounting Firm	F-3

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Estimated costs to complete certain technology integration consulting services contracts

As discussed in Notes 1 and 2 to the consolidated financial statements, revenues from contracts for technology integration consulting services where the Company designs, builds, and implements new or enhanced system applications and related processes for its clients are recognized over time since control of the system is transferred continuously to the client. Generally, revenue is recognized using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying the Company’s performance obligations, which typically occurs over time periods ranging from six months to two years.

We identified the evaluation of estimated costs to complete certain technology integration consulting services contracts as a critical audit matter. Subjective auditor judgment was required to evaluate the estimate of costs to complete the contracts.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s process for estimating costs to complete technology integration consulting services contracts, including controls over the estimate of costs to complete the contracts. We tested the estimated costs to complete for certain technology integration consulting services contracts by evaluating:

•the scope of the work and timing of delivery for consistency with the underlying contractual terms;

•the estimated costs to complete in relation to progress towards satisfying the Company’s performance obligations, based on internal and customer-facing information;

•changes to estimated costs, if any, including the amount and timing of the change based on internal information or contractual changes; and

•actual costs incurred subsequent to the balance sheet date to assess if they were consistent with the estimate for that time period.

We evaluated the Company’s ability to estimate costs by comparing estimates developed at contract inception to actual costs ultimately incurred to satisfy the performance obligation.

Unrecognized tax benefits

As discussed in Note 11 to the consolidated financial statements, the Company has $1,905 million of unrecognized tax benefits as of August 31, 2024. As discussed in Note 1 to the consolidated financial statements, the Company recognizes tax positions when it believes such positions are more likely than not of being sustained if challenged. Recognized tax positions are measured at the largest amount of benefit greater than 50 percent likely of being realized. The Company uses estimates and assumptions in determining the amount of unrecognized tax benefits.

We identified the evaluation of the Company’s unrecognized tax benefits related to transfer pricing and certain other intercompany transactions as a critical audit matter. Complex auditor judgment was required in evaluating the Company’s interpretation of tax law and its analysis of the recognition and measurement of its tax positions.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s unrecognized tax benefits process, including controls over transfer pricing and certain other intercompany transactions. We involved tax and transfer pricing professionals with specialized skills and knowledge, who assisted in:

•evaluating the Company’s interpretation of tax laws and income tax consequences of intercompany transactions, including internal restructurings and intra-entity transfers of assets;


Table of Contents
ACCENTURE 2024 FORM 10-K	Report of Independent Registered Public Accounting Firm	F-4

•assessing transfer pricing studies for compliance with applicable laws and regulations;

•analyzing the Company’s tax positions, including the methodology over measurement of unrecognized tax benefits related to transfer pricing;

•evaluating the Company’s determination of unrecognized tax benefits, including the associated effect in other jurisdictions; and

•inspecting settlements with applicable taxing authorities.

In addition, we evaluated the Company’s ability to estimate its unrecognized tax benefits by comparing historical unrecognized tax benefits to actual results upon the conclusion of examinations by applicable taxing authorities.

/s/

We have served as the Company’s auditor since 2002.

October 10, 2024


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars, except share and per share amounts)
ACCENTURE 2024 FORM 10-K		F-5

Consolidated Balance Sheets

August 31, 2024 and 2023

August 31,
2024

August 31,
2023

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

Short-term investments

Receivables and contract assets

Other current assets

Total current assets

NON-CURRENT ASSETS:

Contract assets

Investments

Property and equipment, net

Lease assets

Goodwill

Deferred contract costs

Deferred tax assets

Intangibles

Other non-current assets

Total non-current assets

TOTAL ASSETS

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Current portion of long-term debt and bank borrowings

Accounts payable

Deferred revenues

Accrued payroll and related benefits

Income taxes payable

Lease liabilities

Other accrued liabilities

Total current liabilities

NON-CURRENT LIABILITIES:

Long-term debt

Deferred revenues

Retirement obligation

Deferred tax liabilities

Income taxes payable

Lease liabilities

Other non-current liabilities

Total non-current liabilities

COMMITMENTS AND CONTINGENCIES

euros per share, shares authorized and issued as of August 31, 2024 and August 31, 2023

Class A ordinary shares, par value $ per share, shares authorized, and shares issued as of August 31, 2024 and August 31, 2023, respectively

Class X ordinary shares, par value $ per share, shares authorized, and shares issued and outstanding as of August 31, 2024 and August 31, 2023, respectively

Restricted share units

Additional paid-in capital

Treasury shares, at cost: Ordinary, shares as of August 31, 2024 and August 31, 2023; Class A ordinary, and shares as of August 31, 2024 and August 31, 2023, respectively

()

Retained earnings

Accumulated other comprehensive loss

()

Total Accenture plc shareholders’ equity

Noncontrolling interests

Total shareholders’ equity

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars, except share and per share amounts)
ACCENTURE 2024 FORM 10-K		F-6

Consolidated Income Statements

For the Years Ended August 31, 2024, 2023 and 2022


	2024	2023	2022
REVENUES:
Revenues	$	$	$
OPERATING EXPENSES:
Cost of services
Sales and marketing
General and administrative costs

Business optimization costs
Total operating expenses
OPERATING INCOME
Interest income
Interest expense	()	()	()
Other income (expense), net	()		()
Loss on disposition of Russia business			()


INCOME BEFORE INCOME TAXES
Income tax expense
NET INCOME
Net income attributable to noncontrolling interests in Accenture Canada Holdings Inc.	()	()	()
Net income attributable to noncontrolling interests – other	()	()	()
NET INCOME ATTRIBUTABLE TO ACCENTURE PLC	$	$	$
Weighted average Class A ordinary shares:
Basic
Diluted
Earnings per Class A ordinary share:
Basic	$	$	$
Diluted	$	$	$
Cash dividends per share	$	$	$

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars)
ACCENTURE 2024 FORM 10-K		F-7

Consolidated Statements of Comprehensive Income

For the Years Ended August 31, 2024, 2023 and 2022


	2024	2023	2022
NET INCOME	$	$	$
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:
Foreign currency translation			()
Defined benefit plans	()
Cash flow hedges		()	()

OTHER COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO ACCENTURE PLC			()
Other comprehensive income (loss) attributable to noncontrolling interests			()
COMPREHENSIVE INCOME	$	$	$

COMPREHENSIVE INCOME ATTRIBUTABLE TO ACCENTURE PLC	$	$	$
Comprehensive income attributable to noncontrolling interests
COMPREHENSIVE INCOME	$	$	$

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars and share amounts)
ACCENTURE 2024 FORM 10-K		F-8

Consolidated Shareholders’ Equity Statements

For the Years Ended August 31, 2024, 2023 and 2022

Ordinary
Shares

Class A
Ordinary
Shares

Class X
Ordinary
Shares

Restricted Share Units

Additional Paid-in Capital

Treasury Shares

Accumulated Other Comprehensive Loss

Total Accenture plc Shareholders’ Equity

Noncontrolling Interests

Total Shareholders’ Equity

No. Shares

Retained Earnings

Balance as of August 31, 2021

()

Net income

Other comprehensive income (loss)

()

Purchases of Class A shares

()

Share-based compensation expense

Purchases/redemptions of Accenture Canada Holdings Inc. exchangeable shares and Class X shares

()

Issuances of Class A ordinary shares for employee share programs

()

Dividends

()

Other, net

()

Balance as of August 31, 2022

()

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars and share amounts)
ACCENTURE 2024 FORM 10-K		F-9

Consolidated Shareholders’ Equity Statements — (continued)

For the Years Ended August 31, 2024, 2023 and 2022

Ordinary
Shares

Class A
Ordinary
Shares

Class X
Ordinary
Shares

Restricted Share Units

Additional Paid-in Capital

Treasury Shares

Accumulated Other Comprehensive Loss

Total Accenture plc Shareholders’ Equity

Noncontrolling Interests

Total Shareholders’ Equity

No. Shares

Retained Earnings

Net income

Other comprehensive income (loss)

Purchases of Class A shares

()

Cancellation of treasury shares

()

Share-based compensation expense

Purchases/redemptions of Accenture Canada Holdings Inc. exchangeable shares and Class X shares

()

Issuances of Class A shares for employee share programs

()

Dividends

()

Other, net

()

Balance as of August 31, 2023

()

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars and share amounts)
ACCENTURE 2024 FORM 10-K		F-10

Consolidated Shareholders’ Equity Statements — (continued)

For the Years Ended August 31, 2024, 2023 and 2022

Ordinary
Shares

Class A
Ordinary
Shares

Class X
Ordinary
Shares

Restricted Share Units

Additional Paid-in Capital

Treasury Shares

Accumulated Other Comprehensive Loss

Total Accenture plc Shareholders’ Equity

Noncontrolling Interests

Total Shareholders’ Equity

No. Shares

Retained Earnings

Net income

Other comprehensive income (loss)

Purchases of Class A shares

()

Share-based compensation expense

Purchases/redemptions of Accenture Canada Holdings Inc. exchangeable shares and Class X shares

()

Issuances of Class A shares for employee share programs

()

Dividends

()

Other, net

()

)

()

Balance as of August 31, 2024

()

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Consolidated Financial Statements (In thousands of U.S. dollars)
ACCENTURE 2024 FORM 10-K		F-11

Consolidated Cash Flows Statements

For the Years Ended August 31, 2024, 2023 and 2022


	2024	2023	2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	$	$
Adjustments to reconcile Net income to Net cash provided by (used in) operating activities—
Depreciation, amortization and other
Share-based compensation expense
Deferred tax expense (benefit)	()	()	()
Other, net	()	()	()
Change in assets and liabilities, net of acquisitions—
Receivables and contract assets, current and non-current	()		()
Other current and non-current assets	()	()	()
Accounts payable		()
Deferred revenues, current and non-current
Accrued payroll and related benefits	()	()
Income taxes payable, current and non-current
Other current and non-current liabilities	()	()	()
Net cash provided by (used in) operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	()	()	()
Purchases of businesses and investments, net of cash acquired	()	()	()
Proceeds from the sale of businesses and investments, net of cash transferred			()
Other investing, net
Net cash provided by (used in) investing activities	()	()	()
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of shares
Purchases of shares	()	()	()
Proceeds from debt
Repayments of debt	()
Cash dividends paid	()	()	()
Other financing, net	()	()	()
Net cash provided by (used in) financing activities	()	()	()
Effect of exchange rate changes on cash and cash equivalents	()	()	()
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	()		()
CASH AND CASH EQUIVALENTS, beginning of period
CASH AND CASH EQUIVALENTS, end of period	$	$	$
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	$	$
Income taxes paid, net	$	$	$

The accompanying Notes are an integral part of these Consolidated Financial Statements.


Table of Contents	Notes to Consolidated Financial Statements (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-12

geographic markets: North America, EMEA (Europe, Middle East and Africa) and Growth Markets. We combine our strength in technology and leadership in cloud, data and AI with unmatched industry experience, functional expertise and global delivery capability to help the world’s leading organizations build their digital core, optimize their operations, accelerate revenue growth and enhance services—creating tangible value at speed and scale.% as of August 31, 2024 and 2023, respectively.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-13

to . Generally, revenue, including estimated fees, is recognized using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying our performance obligations. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the client.

Non-Technology Integration Consulting Services

Our contracts for non-technology integration consulting services are typically less than in duration. Revenues are generally recognized over time as our clients benefit from the services as they are performed, or the contract, for which the related services lack an alternative use, includes termination provisions enabling payment for performance completed to date. When contractual billings represent an amount that corresponds directly with the value provided to the client (e.g., time-and-materials contracts), revenues are recognized as amounts become billable in accordance with contract terms. Revenues from fixed-price contracts are generally recognized using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying our performance obligations. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the client. For non-technology integration consulting contracts which do not qualify to recognize revenue over time, we recognize revenues at a point in time when the client obtains control of the promised good or service.

Contract Estimates

Estimates of total contract revenues and costs are continuously monitored over the lives of our contracts, and recorded revenues and cost estimates are subject to revision as the contract progresses. If at any time the estimate of contract profitability indicates an anticipated loss on a technology integration consulting contract, we recognize the loss in the quarter it first becomes probable and reasonably estimable.

Contract Balances

The timing of revenue recognition, billings and cash collections results in Receivables, Contract assets, and Deferred revenues (Contract liabilities) on our Consolidated Balance Sheet. Amounts are billed as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals (e.g., monthly or quarterly) or upon achievement of contractual milestones. In limited circumstances, we agree to extend financing to certain clients. The terms vary by contract, but generally payment for services is contractually linked to the achievement of specified performance milestones. When the period between payment and transfer of goods or services is one year or less, we do not assess the existence of, and therefore, do not adjust the promised amount of consideration for the effects of a significant financing component. Our receivables are rights to consideration that are conditional only upon the passage of time as compared to our contract assets, which are rights to consideration conditional upon additional factors. When we bill or receive payments from our clients before revenue is recognized, we record Contract liabilities. Contract assets and liabilities are reported on our Consolidated Balance Sheet on a contract-by-contract basis at the end of each reporting period.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-14

and $, respectively. The change in the allowance is primarily due to changes in gross client receivables, contract assets and immaterial write-offs.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-15

$ Investments without readily determinable fair values Total non-current investments$ $

Depreciation and Amortization

$ $

Amortization—Deferred transition

Amortization—Intangible assets

Operating lease cost Other Total depreciation, amortization and other$ $ $ to yearsFurniture and fixtures

to years

Leasehold improvements

Lesser of lease term or years

impairment existed as of August 31, 2024 or 2023, as each reportable segment’s estimated fair value substantially exceeded its carrying value.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-16

Operating Expenses

$ $ Advertising costs (1) Provision for (release of) doubtful accounts (2) ()

(1)Advertising costs are expensed as incurred.

Business Optimization

During the second quarter of fiscal 2023, we initiated actions to streamline our operations, transform our non-billable corporate functions and consolidate our office space to reduce costs. We recorded a total of $ billion related to these actions, primarily for employee severance, which have been completed as of August 31, 2024.

$ EMEA (1) Growth Markets (1) Total business optimization costs$ $

(1)During the first quarter of fiscal 2024, we revised the reporting of our geographic markets for the movement of our Middle East and Africa market units from Growth Markets to Europe, and the Europe market became our EMEA (Europe, Middle East and Africa) geographic market. Prior period amounts have been reclassified to conform with the current period presentation.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-17

billion and $ billion as of August 31, 2024 and 2023, respectively. Our remaining performance obligations represent the amount of transaction price for which work has not been performed and revenue has not been recognized. The majority of our contracts are terminable by the client on short notice with little or no termination penalties, and some without notice. Under Topic 606, only the non-cancelable portion of these contracts is included in our performance obligations. Additionally, our performance obligations only include variable consideration if we assess it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty is resolved. Based on the terms of our contracts, a significant portion of what we consider contract bookings is not included in our remaining performance obligations. We expect to recognize approximately % of our remaining performance obligations as of August 31, 2024 as revenue in fiscal 2025, an additional % in fiscal 2026, and the balance thereafter.

Contract Estimates

Adjustments in contract estimates related to performance obligations satisfied or partially satisfied in prior periods were immaterial for both fiscal 2024 and 2023.

Contract Balances

Deferred transition revenues were $ and $ as of August 31, 2024 and 2023, respectively, and are included in Non-current deferred revenues. Costs related to these activities are also deferred and are expensed as the services are provided. Generally, deferred amounts are protected in the event of early termination of the contract and are monitored regularly for impairment. Impairment losses are recorded when projected remaining undiscounted operating cash flows of the related contract are not sufficient to recover the carrying amount of contract assets. Deferred transition costs were $ and $ as of August 31, 2024 and 2023, respectively, and are included in Deferred contract costs. Deferred transition amortization expense for fiscal 2024, 2023 and 2022 was $, $ and $, respectively.

$ Contract assets (current) Receivables and contract assets, net of allowance (current) Contract assets (non-current) Deferred revenues (current) Deferred revenues (non-current)

Changes in the contract asset and liability balances during fiscal 2024, were a result of normal business activity and not materially impacted by any other factors.

Revenues recognized during fiscal 2024 that were included in Deferred revenues as of August 31, 2023 were $ billion. Revenues recognized during fiscal 2023 that were included in Deferred revenues as of August 31, 2022 were $ billion.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-18

$ $ Basic weighted average Class A ordinary shares Basic earnings per share$ $ $ Diluted Earnings per shareNet income attributable to Accenture plc$ $ $ Net income attributable to noncontrolling interests in Accenture Canada Holdings Inc. (1) Net income for diluted earnings per share calculation$ $ $ Basic weighted average Class A ordinary shares Class A ordinary shares issuable upon redemption/exchange of noncontrolling interests (1) Diluted effect of employee compensation related to Class A ordinary shares Diluted effect of share purchase plans related to Class A ordinary shares Diluted weighted average Class A ordinary shares (2) Diluted earnings per share$ $ $

(1)Diluted earnings per share assumes the exchange of all Accenture Canada Holdings Inc. exchangeable shares for Accenture plc Class A ordinary shares on a -for-one basis. The income effect does not take into account “Net income attributable to noncontrolling interests - other,” since those shares are not redeemable or exchangeable for Accenture plc Class A ordinary shares.

(2)The weighted average diluted shares outstanding for the calculation of diluted earnings per share excludes an immaterial amount of shares issuable upon the vesting of restricted stock units because their effects were antidilutive.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-19

)$()$() Foreign currency translation () Income tax benefit (expense) Portion attributable to noncontrolling interests()() Foreign currency translation, net of tax () Ending balance()()()Defined benefit plans Beginning balance()()() Actuarial gains (losses)() Pension settlement()() Prior service costs arising during the period() Reclassifications into net periodic pension and
post-retirement expense Income tax benefit (expense) ()() Portion attributable to noncontrolling interests ()() Defined benefit plans, net of tax() Ending balance()()()Cash flow hedges Beginning balance() Unrealized gain (loss) ()() Reclassification adjustments into Cost of services() () Income tax benefit (expense) Portion attributable to noncontrolling interests() Cash flow hedges, net of tax ()() Ending balance (1)()() Accumulated other comprehensive loss$()$()$()

of net unrealized gains related to derivatives designated as cash flow hedges is expected to be reclassified into cost of services in the next twelve months.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-20

$ Furniture and fixtures Leasehold improvements Property and equipment, gross Total accumulated depreciation()()Property and equipment, net$ $

, $ and $, respectively.

$ $ Goodwill Intangible assets

The intangible assets primarily consist of customer-related intangibles, which are being amortized over one to . The goodwill was allocated among our reportable operating segments and is partially deductible for U.S. federal income tax purposes.

Dispositions

During fiscal 2022, we disposed of our business in Russia, which was part of our Europe segment (now referred to as our EMEA segment). The transaction resulted in a non-operating loss of $, which was not deductible for tax purposes and did not have a material effect on our operations or financial results.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-21

$ $()$ $ $ $ EMEA (1) Growth Markets (1) () Total$ $ $ $ $ $ $

Goodwill includes immaterial adjustments related to prior period acquisitions.

Intangible Assets

$()$ $ $()$ Technology () () Patents () () Other () () Total$ $()$ $ $()$

Total amortization related to our intangible assets was $, $ and $ for fiscal 2024, 2023 and 2022, respectively.

2026 2027 2028 2029 Thereafter Total$


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-22

$ $ Variable lease cost Sublease income()()()Total$ $ $ $ $ Lease assets obtained in exchange for liabilities

As of August 31, 2024 and 2023, our operating leases had a weighted average remaining lease term of and years, respectively, and a weighted average discount rate of % and %, respectively.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-23

$()2026 ()2027 ()2028 ()2029 ()Thereafter ()Total lease payments (receipts)$ $()Less interest()Total lease liabilities$

that are not reflected in the table above. These leases are primarily related to office real estate and will commence in fiscal 2025 with lease terms of up to years.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-24

as of August 31, 2024.

We utilize standard counterparty master agreements containing provisions for the netting of certain foreign currency transaction obligations and for set-off of certain obligations in the event of an insolvency of one of the parties to the transaction. These provisions may reduce our potential overall loss resulting from the insolvency of a counterparty and reduce a counterparty’s potential overall loss resulting from our insolvency. Additionally, these agreements contain early termination provisions triggered by adverse changes in a counterparty’s credit rating, thereby enabling us to accelerate settlement of a transaction prior to its contractual maturity and potentially decrease our realized loss on an open transaction. Similarly, a decrement in our credit rating could trigger a counterparty’s early termination rights, thereby enabling a counterparty to accelerate settlement of a transaction prior to its contractual maturity and potentially increase our realized loss on an open transaction. The aggregate fair value of our derivative instruments with credit-risk-related contingent features that were in a liability position as of August 31, 2024 was $.

Our derivative financial instruments consist of deliverable and non-deliverable foreign currency forward contracts. Fair values for derivative financial instruments are based on prices computed using third-party valuation models and are classified as Level 2 in accordance with the three-level hierarchy of fair value measurements. All of the significant inputs to the third-party valuation models are observable in active markets. Inputs include current market-based parameters such as forward rates and yield curves. For additional information related to the three-level hierarchy of fair value measurements, see Note 12 (Retirement and Profit Sharing Plans) to these Consolidated Financial Statements.

Cash Flow Hedges

Certain of our subsidiaries are exposed to currency risk through their use of our global delivery resources. To mitigate this risk, we use foreign currency forward contracts to hedge the foreign exchange risk of the forecasted intercompany expenses denominated in foreign currencies for up to three years in the future. We have designated these derivatives as cash flow hedges. As of August 31, 2024 and 2023, we held no derivatives that were designated as fair value or net investment hedges.

In order for a derivative to qualify for hedge accounting, the derivative must be formally designated as a fair value, cash flow or net investment hedge by documenting the relationship between the derivative and the hedged item. The documentation includes a description of the hedging instrument, the hedged item, the risk being hedged, our risk management objective and strategy for undertaking the hedge, the method for assessing the effectiveness of the hedge and the method for measuring hedge ineffectiveness. Additionally, the hedge relationship must be expected to be highly effective at offsetting changes in either the fair value or cash flows of the hedged item at both inception of the hedge and on an ongoing basis.

For a cash flow hedge, the effective portion of the change in estimated fair value of a hedging instrument is recorded in Accumulated other comprehensive loss as a separate component of Shareholders’ Equity and is reclassified into Cost of services in the Consolidated Income Statements during the period in which the hedged transaction is recognized. The amounts related to derivatives designated as cash flow hedges that were reclassified into Cost of services were net gains of $, net losses of $ and net gains of $ during fiscal 2024, 2023 and 2022, respectively. The ineffective portion of the change in fair value of a cash flow hedge is recognized immediately in Other income (expense), net in the Consolidated Income Statements and for fiscal 2024, 2023 and 2022, was not material. In addition, we did not discontinue any cash flow hedges during fiscal 2024, 2023 or 2022.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-25

, $ and $ for fiscal 2024, 2023 and 2022, respectively. Gains and losses on these contracts are recorded in Other income (expense), net in the Consolidated Income Statements and are offset by gains and losses on the related hedged items.

Fair Value of Derivative Instruments

$ Other non-current assets Other DerivativesOther current assets Total assets$ $ LiabilitiesCash Flow HedgesOther accrued liabilities$ $ Other non-current liabilities Other DerivativesOther accrued liabilities Total liabilities$ $ Total fair value$ $()Total notional value$ $

We utilize standard counterparty master agreements containing provisions for the netting of certain foreign currency transaction obligations and for the set-off of certain obligations in the event of an insolvency of one of the parties to the transaction. In the Consolidated Balance Sheets, we record derivative assets and liabilities at gross fair value.

$ Net derivative liabilities Total fair value$ $()


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-26

10.

and $, respectively. Separate, uncommitted, unsecured multicurrency revolving credit facilities (2) Local guaranteed and non-guaranteed lines of credit (3) Total$

(1)On May 14, 2024, we replaced our $ syndicated credit facility with a new $ syndicated credit facility maturing on May 14, 2029. This facility provides unsecured, revolving borrowing capacity for general corporate capital purposes, including the issuance of letters of credit and short-term commercial paper. Borrowings under this facility will accrue interest at the applicable risk-free rate plus a spread. We continue to be in compliance with relevant covenant terms. The facility is subject to annual commitment fees. As of August 31, 2024, we had $ of commercial paper outstanding (excluding unamortized discounts) and backed by this facility, with a weighted-average effective interest rate of %, maturing at various dates through the first quarter of fiscal 2025. As of August 31, 2023 we had $ of commercial paper outstanding backed by our $ syndicated credit facility, with a weighted-average effective interest rate of %.

(2)We maintain separate, uncommitted and unsecured multicurrency revolving credit facilities. These facilities provide local currency financing for the majority of our operations. Interest rate terms on the revolving facilities are at market rates prevailing in the relevant local markets. As of August 31, 2024 and 2023, we had borrowings under these facilities.

(3)We also maintain local guaranteed and non-guaranteed lines of credit for those locations that cannot access our global facilities. As of August 31, 2024 and 2023, we had borrowings under these various facilities.

We had an aggregate of $ and $ of letters of credit outstanding and $ (excluding unamortized discounts) and $ of commercial paper outstanding as of August 31, 2024 and 2023, respectively. The amount of letters of credit and commercial paper outstanding reduces the available borrowing capacity under these facilities.

Subsequent Events

On October 4, 2024, Accenture Capital Inc. (“Accenture Capital”), an indirect wholly owned finance subsidiary of Accenture plc, issued $ billion aggregate principal amount of senior unsecured notes, comprised of $ billion of % senior notes due October 4, 2027, $ billion of % senior notes due October 4, 2029, $ billion of % senior notes due October 4, 2031 and $ billion of % senior notes due October 4, 2034. Accenture plc fully and unconditionally guarantees these notes. Net proceeds from the offering will be used for general corporate purposes, including repayment of outstanding commercial paper borrowings. Interest on the senior unsecured notes is payable semi-annually in arrears. Accenture Capital may redeem the senior unsecured notes at any time in whole, or from time to time, in part at specified redemption prices. Accenture plc and Accenture Capital are not subject to any financial covenants under the senior unsecured notes.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-27

11.

$ $ U.S. state and local Non-U.S. Total current tax expense Deferred taxesU.S. federal()()()U.S. state and local()()()Non-U.S. Total deferred tax (benefit) expense ()()()Total$ $ $ $ $ Non-U.S. sources Total$ $ $ % % %U.S. state and local taxes, net Non-U.S. operations taxed at other rates Final determinations (1)()()()Other net activity in unrecognized tax benefits
Excess tax benefits from share based payments()()()Foreign-derived intangible income deduction()()()Other, net Effective income tax rate % % %

(1)Final determinations include final agreements with tax authorities and expirations of statutes of limitations.

(2)Prior period amounts have been reclassified to conform with the current period presentation.

As of August 31, 2024, we had not recognized a deferred tax liability on approximately $ of undistributed earnings for certain foreign subsidiaries, because these earnings are intended to be indefinitely reinvested. If such earnings were distributed, some countries may impose additional taxes. The unrecognized deferred tax liability (the amount payable if distributed) is approximately $.

Portions of our operations are subject to reduced tax rates or are free of tax under various tax holidays which expire through fiscal 2031. The income tax benefits attributable to the tax status of these subsidiaries were estimated to be approximately $, $ and $ in fiscal 2024, 2023 and 2022, respectively.

The revaluation of deferred tax assets and liabilities due to enacted changes in tax laws and tax rates did not have a material impact on our effective tax rate in fiscal 2024, 2023, or 2022.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-28

$ Compensation and benefits Share-based compensation Tax credit carryforwards Net operating loss carryforwards Deferred amortization deductions Indirect effects of unrecognized tax benefits Licenses and other intangibles Leases Capitalized research costs Other Total deferred tax assets Valuation allowance()()Deferred tax assets, net of valuation allowance Deferred tax liabilitiesPensions()()Investments in subsidiaries()()Intangibles()()Leases()()Other()()Total deferred tax liabilities()()Net deferred tax assets$ $

(1)Prior period amounts have been reclassified to conform with the current period presentation.

We recorded valuation allowances of $ and $ as of August 31, 2024 and 2023, respectively, against deferred tax assets principally associated with certain tax credit and tax net operating loss carryforwards, as we believe it is more likely than not that these assets will not be realized. For all other deferred tax assets, we believe it is more likely than not that the results of future operations will generate sufficient taxable income to realize these deferred tax assets. During fiscal 2024 and 2023, we recorded net increases of $ and $ in the valuation allowance, respectively, primarily related to valuation allowances on certain tax credit carryforwards, as we believe it is more likely than not that these assets will not be realized.

We had tax credit carryforwards as of August 31, 2024 of $, of which $ will expire between 2025 and 2034 and $ has an indefinite carryforward period. We had net operating loss carryforwards as of August 31, 2024 of $. Of this amount, $ expires between 2025 and 2034, $ expires between 2035 and 2044, and $ has an indefinite carryforward period.

As of August 31, 2024, we had $ of unrecognized tax benefits, of which $, if recognized, would favorably affect our effective tax rate. As of August 31, 2023, we had $ of unrecognized tax benefits, of which $, if recognized, would favorably affect our effective tax rate. The remaining unrecognized tax benefits as of August 31, 2024 and 2023 of $ and $, respectively, represent items recorded as offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes and timing adjustments.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-29

$ Additions for tax positions related to the current year Additions for tax positions related to prior years Reductions for tax positions related to prior years()()Statute of limitations expirations()()Settlements with tax authorities()()Cumulative translation adjustment Balance, end of year$ $

We recognize interest and penalties related to unrecognized tax benefits in our Income tax expense. During fiscal 2024, 2023 and 2022, we recognized expense of $, $ and $ in interest and penalties, respectively. Accrued interest and penalties related to unrecognized tax benefits of $ ($, net of tax benefits) and $ ($, net of tax benefits) were reflected on our Consolidated Balance Sheets as of August 31, 2024 and 2023, respectively.

As a global company, we file tax returns in multiple tax jurisdictions including the U.S. and Ireland. We have participated in the U.S. Internal Revenue Service (“IRS”) Compliance Assurance Process (“CAP”) program since fiscal 2016. CAP tax years are examined by the IRS on a contemporaneous basis so that most issues are resolved prior to filing the tax return. The years from fiscal 2021 forward remain open for examination by the IRS. The years from fiscal 2020 forward remain open for examination by the Irish tax authorities. We are currently under audit in U.S. state and other non-U.S. tax jurisdictions. However, with limited exceptions, we are no longer subject to examination by those taxing authorities for years before 2016. Although the outcome of tax audits is always uncertain and could result in significant cash tax payments, we do not believe the outcome of these audits will have a material adverse effect on our consolidated financial position or results of operations. We believe that it is reasonably possible that our unrecognized tax benefits could decrease by approximately $ or increase by approximately $ in the next 12 months as a result of settlements, lapses of statutes of limitations, tax audit activity and other adjustments. The majority of these amounts relate to transfer pricing matters in both U.S. and non-U.S. tax jurisdictions.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-30

12.

% % % % % % % % %Discount rate for determining net periodic pension expense % % % % % % % % %Long term rate of return on plan assets % % % % % % % % %Rate of increase in future compensation for determining projected benefit obligation % % % % % %N/AN/AN/ARate of increase in future compensation for determining net periodic pension expense % % % % % %N/AN/AN/AInterest crediting rate for determining projected benefit obligationN/A %N/A %N/A %N/AN/AN/AInterest crediting rate for determining net periodic pension expenseN/A %N/A %N/A %N/AN/AN/A

We utilize a full yield curve approach to estimate the service and interest cost components by applying specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. This approach provides a correlation between projected benefit cash flows and the corresponding yield curve spot rates and provides a precise measurement of service and interest costs. The discount rate assumptions are based on the expected duration of the benefit payments for each of our defined benefit pension and postretirement plans as of the annual measurement date and are subject to change each year.

The expected long-term rate of return on plan assets should, over time, approximate the actual long-term returns on defined benefit pension and postretirement plan assets and is based on historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the asset portfolio.

Assumed U.S. Health Care Cost Trend

Our U.S. postretirement plan assumed annual rate of increase in the per capita cost of health care benefits is % for the plan year ending August 31, 2025. The rate is assumed to decrease on a straight-line basis to % for the plan year ending August 31, 2049 and remain at that level thereafter.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-31

, $ and $, respectively. Postretirement expense for fiscal 2024, 2023 and 2022 was not material to our Consolidated Financial Statements. The service cost component of pension and postretirement expense is included in operating expenses while the other components of net benefit cost are included in Other income (expense), net.

Benefit Obligation, Plan Assets and Funded Status

$ $ $ $ $ Service cost Interest cost Participant contributions Acquisitions/divestitures/transfers Amendments () Special termination benefits Plan combinations Actuarial (gain) loss() ()() ()Benefits paid()()()()()()Exchange rate impact () ()()Benefit obligation, end of year$ $ $ $ $ $ Reconciliation of fair value of plan assetsFair value of plan assets, beginning of year$ $ $ $ $ $ Actual return on plan assets ()() ()Acquisitions/divestitures/transfers Employer contributions Participant contributions Benefits paid()()()()()()Exchange rate impact () Fair value of plan assets, end of year$ $ $ $ $ $ Funded status, end of year$()$()$()$()$()$()Amounts recognized in the Consolidated Balance SheetsNon-current assets$ $ $ $ $ $ Current liabilities()()()()()()Non-current liabilities()()()()()()Funded status, end of year$()$()$()$()$()$()


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-32

$ $ $ $()$()Prior service (credit) cost () () Accumulated other comprehensive (gain) loss, pre-tax$ $ $ $ $()$()

Funded Status for Defined Benefit Plans

$ $ $ $ $ $ $ $ Fair value of plan assets $ $ $ Fair value of plan assets

Investment Strategies

U.S. Pension Plans

The overall investment objective of the defined benefit pension plans is to match the duration of the plans’ assets to the plans’ liabilities while managing risk in order to meet current defined benefit pension obligations. The plans’ future prospects, their current financial conditions, our current funding levels and other relevant factors suggest that the plans can tolerate some interim fluctuations in market value and rates of return in order to achieve long-term objectives without undue risk to the plans’ ability to meet their current benefit obligations. We recognize that asset allocation of the defined benefit pension plans’ assets is an important factor in determining long-term performance. Actual asset allocations at any point in time may


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-33

% % % % % %Debt securities Cash and short-term investments Insurance contracts Other Total % % % % % %

Fair Value Measurements

Fair value is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity.

The three-level hierarchy of fair value measurements is based on whether the inputs to those measurements are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The fair-value hierarchy requires the use of observable market data when available and consists of the following levels:

•Level 1—Quoted prices for identical instruments in active markets;

•Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets; and

•Level 3—Valuations derived from valuation techniques in which one or more significant inputs are unobservable.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-34

$ $ $ Fixed IncomeU.S. government, state and local debt securities
Non-U.S. government debt securities Non-U.S. corporate debt securities Mutual fund debt securities Cash and short-term investments Insurance contracts Other Total$ $ $ $

The level 3 assets are primarily invested in an insurance buy-in contract in a Non-U.S. plan. The fair value of the assets is set to an actuarially calculated present value of the underlying liabilities.

The U.S. Plans have $ in Level 2 assets, primarily made up of U.S. corporate debt securities of $ and U.S. government, state and local debt securities of $.

Changes in fair value Ending Balance$ $ $ $ Non-U.S. corporate equity securities Fixed IncomeNon-U.S. government debt securities Non-U.S. corporate debt securities Mutual fund debt securities Cash and short-term investments Insurance contracts Other Total$ $ $ $

The U.S. Plans have $ in Level 2 assets, primarily made up of U.S. corporate debt securities of $ and U.S. government, state and local debt securities of $.

Changes in fair value Ending Balance$


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-35

in fiscal 2025 related to contributions to our U.S. and non-U.S. defined benefit pension plans and benefit payments related to the unfunded frozen plan for former pre-incorporation partners. We have not determined whether we will make additional voluntary contributions for our defined benefit pension plans. Our postretirement plan contributions in fiscal 2025 are not expected to be material to our Consolidated Financial Statements.

Estimated Future Benefit Payments

$ $ 2026 2027 2028 2029 2030-2034

Defined Contribution Plans

, $ and $ in fiscal 2024, 2023 and 2022, respectively.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-36

13.

Accenture plc Class A ordinary shares are currently authorized for awards under the Amended 2010 SIP. As of August 31, 2024, there were shares available for future grants. Accenture plc Class A ordinary shares covered by awards that terminate, lapse or are cancelled may again be used to satisfy awards under the Amended 2010 SIP. We issue new Accenture plc Class A ordinary shares and shares from treasury for shares delivered under the Amended 2010 SIP. $ $ Income tax benefit related to share-based compensation included in Net income

Restricted Share Units

Under the Amended 2010 SIP, participants may be, and previously under the predecessor 2001 Share Incentive Plan were, granted restricted share units, each of which represent an unfunded, unsecured right to receive an Accenture plc Class A ordinary share on the date specified in the participant’s award agreement. The fair value of the awards is based on our stock price on the date of grant. The restricted share units granted under these plans are subject to cliff or graded vesting, generally ranging from two to . For awards with graded vesting, compensation expense is recognized over the vesting term of each separately vesting portion. Compensation expense is recognized on a straight-line basis for awards with cliff vesting.

$ Granted (1) Vested (2)() Forfeited() Nonvested balance as of August 31, 2024 $

(1)The weighted average grant-date fair value for restricted share units granted for fiscal 2024, 2023 and 2022 was $, $ and $, respectively.

, $ and $, respectively.

As of August 31, 2024, there was $ of total unrecognized restricted share unit compensation expense related to nonvested awards, which is expected to be recognized over a weighted average period of years. As of August 31, 2024, there were restricted share units vested but not yet delivered as Accenture plc Class A ordinary shares.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-37

% to % of their eligible compensation during each semi-annual offering period (up to $ per offering period) to purchase Accenture plc Class A ordinary shares at a discount. Under the VEIP, eligible members of Accenture Leadership may elect to contribute up to % of their eligible compensation towards the monthly purchase of Accenture plc Class A ordinary shares at fair market value. At the end of the VEIP program year, Accenture Leadership participants who did not withdraw from the program will be granted restricted share units under the Amended 2010 SIP equal to % of the number of shares purchased during that year and held by the participant as of the grant date.

Accenture plc Class A ordinary shares may be issued under the 2010 ESPP. As of August 31, 2024, we had issued Accenture plc Class A ordinary shares under the 2010 ESPP. We issued , and shares to employees in fiscal 2024, 2023 and 2022, respectively, under the 2010 ESPP.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-38

14.

authorized ordinary shares, par value € per share. Each ordinary share of Accenture plc entitles its holder to receive payments upon a liquidation of Accenture plc; however a holder of an ordinary share is not entitled to vote on matters submitted to a vote of shareholders of Accenture plc or to receive dividends.

Class A Ordinary Shares

An Accenture plc Class A ordinary share entitles its holder to vote per share, and holders of those shares do not have cumulative voting rights. Each Class A ordinary share entitles its holder to a pro rata part of any dividend at the times and in the amounts, if any, which Accenture plc’s Board of Directors from time to time determines to declare, subject to any preferred dividend rights attaching to any preferred shares. Each Class A ordinary share is entitled on a winding-up of Accenture plc to be paid a pro rata part of the value of the assets of Accenture plc remaining after payment of its liabilities, subject to any preferred rights on liquidation attaching to any preferred shares.

Class X Ordinary Shares

Most of our pre-incorporation partners who received Accenture Canada Holdings Inc. exchangeable shares in connection with our transition to a corporate structure received a corresponding number of Accenture plc Class X ordinary shares. An Accenture plc Class X ordinary share entitles its holder to vote per share, and holders of those shares do not have cumulative voting rights. A Class X ordinary share does not entitle its holder to receive dividends, and holders of those shares are not entitled to be paid any amount upon a winding-up of Accenture plc. Accenture plc may redeem, at its option, any Class X ordinary share for a redemption price equal to the par value of the Class X ordinary share. Accenture plc has separately agreed with the original holders of Accenture Canada Holdings Inc. exchangeable shares not to redeem any Class X ordinary share of such holder if the redemption would reduce the number of Class X ordinary shares held by that holder to a number that is less than the number of Accenture Canada Holdings Inc. exchangeable shares owned by that holder, as the case may be. Accenture plc will redeem Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares so that the aggregate number of Class X ordinary shares outstanding at any time does not exceed the aggregate number of Accenture Canada Holdings Inc. exchangeable shares outstanding. Class X ordinary shares are not transferable without the consent of Accenture plc.

Equity of Subsidiaries Redeemable or Exchangeable for Accenture plc Class A Ordinary Shares

Accenture Canada Holdings Inc. Exchangeable Shares

Pre-incorporation partners resident in Canada and New Zealand received Accenture Canada Holdings Inc. exchangeable shares in connection with our transition to a corporate structure. Holders of Accenture Canada Holdings Inc. exchangeable shares may exchange their shares for Accenture plc Class A ordinary shares at any time on a -for-one basis. We may, at our option, satisfy this exchange with cash at a price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the exchange. Each exchangeable share of Accenture Canada Holdings Inc. entitles its holder to receive distributions equal to any distributions to which an Accenture plc Class A ordinary share entitles its holder.

Share Purchases and Redemptions

The Board of Directors of Accenture plc has authorized funding for our publicly announced open-market share purchase program for acquiring Accenture plc Class A ordinary shares and for purchases and redemptions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership and their permitted transferees. As of August 31, 2024, our aggregate available authorization was $ for our publicly announced open-market share purchase and these other share purchase programs.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-39

$ $ Other share purchase programs Other purchases (2) Total $ $

(1)We conduct a publicly announced open-market share purchase program for Accenture plc Class A ordinary shares. These shares are held as treasury shares by Accenture plc and may be utilized to provide for select employee benefits, such as equity awards to our employees.

Dividends

October 12, 2023$ October 10, 2023$ $ February 15, 2024 January 18, 2024 January 16, 2024 May 15, 2024 April 11, 2024 April 9, 2024 August 15, 2024 July 11, 2024 July 10, 2024 Total Dividends$ $ $

The payment of cash dividends includes the net effect of $ of additional restricted stock units being issued as a part of our share plans, which resulted in restricted share units being issued.

Subsequent Events

On September 25, 2024, the Board of Directors of Accenture plc declared a quarterly cash dividend of $ per share on our Class A ordinary shares for shareholders of record at the close of business on October 10, 2024, payable on November 15, 2024.

On September 25, 2024, the Board of Directors of Accenture plc approved $ in additional share repurchase authority, bringing Accenture’s total outstanding authority to $.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-40

15.

As of August 31, 2024 and 2023, our aggregate potential liability to our clients for expressly limited guarantees involving the performance of third parties was approximately $ and $, respectively, of which all but approximately $ and $, respectively, may be recovered from the other third parties if we are obligated to make payments to the indemnified parties as a consequence of a performance default by the other third parties. For arrangements with unspecified limitations, we cannot reasonably estimate the aggregate maximum potential liability, as it is inherently difficult to predict the maximum potential amount of such payments, due to the conditional nature and unique facts of each particular arrangement.

As of August 31, 2024 and 2023, we have issued or provided guarantees in the form of letters of credit and surety bonds of $ ($ net of recourse provisions) and $ ($ net of recourse provisions) respectively, the majority of which support certain contracts that require us to provide them as a guarantee of our performance. These guarantees are typically renewed annually and remain in place until the contractual obligations are satisfied. In general, we would only be liable for these guarantees in the event we defaulted in performing our obligations under each contract, the probability of which we believe is remote.

To date, we have not been required to make any significant payment under any of the arrangements described above. We have assessed the current status of performance/payment risk related to arrangements with limited guarantees, warranty obligations, unspecified limitations, indemnification provisions, letters of credit and surety bonds, and believe that any potential payments would be immaterial to the Consolidated Financial Statements, as a whole.

Legal Contingencies

As of August 31, 2024, we or our present personnel had been named as a defendant in various litigation matters. We and/or our personnel also from time to time are involved in investigations by various regulatory or legal authorities concerning matters arising in the course of our business around the world. Based on the present status of these matters, except as otherwise noted below, management believes the range of reasonably possible losses in addition to amounts accrued, net of insurance recoveries, will not have a material effect on our results of operations or financial condition.

On July 24, 2019, Accenture was named in a putative class action lawsuit filed by consumers of Marriott International, Inc. (“Marriott”) in the U.S. District Court for the District of Maryland. The complaint alleges negligence by us, and seeks monetary damages, costs and attorneys’ fees and other related relief, relating to a data security incident involving unauthorized access to the reservations database of Starwood Worldwide Resorts, Inc. (“Starwood”), which was acquired by Marriott on September 23, 2016. Since 2009, we have provided certain IT infrastructure outsourcing services to Starwood. On May 3, 2022, the court issued an order granting in part the plaintiffs’ motion for class certification, which we appealed. On August 17, 2023, the appeals court vacated the class certification and remanded the case to the district court for consideration of, among other things, the class action waiver signed by Starwood customer plaintiffs. On November 29, 2023, the district court reinstated the classes previously certified by the court in May 2022. We are appealing the district court's decision. We continue to believe the lawsuit is without merit and we will vigorously defend it. At present, we do not believe any losses from this matter will have a material effect on our results of operations or financial condition.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-41


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-42

16.

reportable segments are our geographic markets, which are North America, EMEA and Growth Markets. $ $ $ Depreciation and amortization (3) Operating income Net assets as of August 31 (4) Property & equipment, net Fiscal 2023Revenues $ $ $ $ Depreciation and amortization (3) Operating income Net assets as of August 31 (4) Property & equipment, net Fiscal 2022Revenues $ $ $ $ Depreciation and amortization (3) Operating income Net assets as of August 31 (4) Property & equipment, net

(1)In the first quarter of fiscal 2025, our Latin America market unit will move from Growth Markets to North America. With this change, North America will become the Americas market and Growth Markets will become the Asia Pacific market.

(3)Amounts include depreciation on property and equipment and amortization of intangible assets and deferred contract costs controlled by each reportable segment, as well as an allocation for amounts they do not directly control.

(4)We do not allocate total assets by reportable segment. Reportable segment assets directly attributable to a reportable segment and provided to the chief operating decision makers include receivables and current and non-current contract assets, deferred contract costs and current and non-current deferred revenues.

The accounting policies of the reportable segments are the same as those described in Note 1 (Summary of Significant Accounting Policies) to these Consolidated Financial Statements.

Our business in the United States represented % of our consolidated revenues during fiscal 2024, 2023 and 2022, respectively. No other country individually comprised 10% or more of our consolidated revenues during these periods. Business in Ireland, our country of domicile, represented approximately % of our consolidated revenues during fiscal 2024, 2023 and 2022.


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-43

% % %India Ireland $ $ Financial Services Health & Public Service Products Resources Total$ $ $ Type of WorkConsulting$ $ $ Managed Services Total$ $ $


Table of Contents	Notes to Consolidated Financial Statements — (continued) (In thousands of U.S. dollars, except share and per share amounts or as otherwise disclosed)
ACCENTURE 2024 FORM 10-K		F-44

17.

$ $ $ $ Cost of services Operating income Net income Net income attributable to Accenture plc Weighted average Class A ordinary shares:—Basic —Diluted Earnings per Class A ordinary share:—Basic$ $ $ $ $ —Diluted$ $ $ $ $

Fiscal 2023

First
Quarter

Second
Quarter

Third
Quarter

Fourth
Quarter

Annual

Revenues

Cost of services

Operating income

Net income

Net income attributable to Accenture plc

Weighted average Class A ordinary shares:

—Basic

—Diluted

Earnings per Class A ordinary share:

—Basic

—Diluted

Accenture plc - Annual Report: 2024 (Form 10-K)

Similar companies